Anthropometric and hormonal-andmetabolic parameters in abdominal obesity
https://doi.org/10.14341/probl11672
Abstract
То examine the distribution of fatty tissue in patients with abdominal obesity by magnetic resonance imaging (MRI) and to evaluate the relationship between the area of visceral fatty tissue and their anthropometric and hormonal-and-metabolic parameters, 31 individuals aged 20-40 years were examined. There were 15 females with a waist circumference (WC) of > 80 cm and a waist-hip ratio (WHR) of > 0.85 and 16 males with > 94 cm and 0.95, respectively. In the course of this study, the authors estimated anthropometric parameters such as body mass, body mass index, WC, and WHR, and measured blood pressure. In all the patients, the areas of visceral and subcutaneous fatty tissues at the level of LIV were determined by MRI; the levels of lipids, lipoproteins, glucose, and insulin were measured. Our study has indicated that predominantly abdominal and visceral obesity was generally combined with hyperinsulinemia and hypercholesterolemia in patients with Stages I and II arterial hypertension. It has been ascertained that it is impossible to diagnose predominant visceral obesity in females, unlike males, by using anthropometric parameters. MRI is the method of choice in verifying the diagnosis of female visceral obesity
About the Authors
A. A. PlokhayaEndocrinology Research Center of RAMS
Russian Federation
A. V. Vorontsov
Endocrinology Research Center of RAMS
Russian Federation
Yu. V. Novolodskaya
Endocrinology Research Center of RAMS
Russian Federation
S. A. Butrova
Endocrinology Research Center of RAMS
Russian Federation
I. I. Dedov
Endocrinology Research Center of RAMS
Russian Federation
References
1. Бутрова С. А. // Рус. мед. журн. - 2001. - Т. 9, № 2. - С. 56-60.
2. Зимин Ю. В. // Кардиология. - 1998. - № 6. - С. 71-81.
3. Зимин Ю. В. и др. // Клин, вестн. - 1998. - № 2. - С. 50-54.
4. Первый Доклад экспертов научного общества по изучению артериальной гипертонии Всероссийского научного общества кардиологов и Межведомственного совета по сердечно-сосудистым заболеваниям (ДАГ 1) // Клин, фар- макол. и тер. - 2000. - № 3. - С. 5-30.
5. Alberti К. G. М. М., Zimmet Р. Z. for the WHO Consultation Group. I I Diabet. Med. - 1998. - Vol. 15. - P. 539-553.
6. Assmann G., Cullen P., Schulte H. // Eur. Heart J. - 1998. - Vol. 19 (A). - P. 3-11.
7. Fvignon A., Boegner C., Mariano-Goulaurt D. et al. // Int. J. Obesity. - 1999. - Vol. 23. - P. 512-517.
8. Caro J. I I J. Clin. Endocrinol. Metab. - 1991. - Vol. 73, N 4. - P. 691-696.
9. DeFronzo R A., Ferrannini E. // Diabetes Care. - 1991. - Vol. 14. - P. 173-194.
10. Ferrannini E. // Contemporary Endocrinology: Insulin Resistance / Eds G. Reaven, A. Laws. - Totowa; New York, 1999. -P. 281-303.
11. Friedwald W. T., Levy R. J., Fredricson D. S. // Clin. Chem. - 1972. - Vol. 18. - P. 499-502.
12. Modan M., Halkin H. et al. // Arteriosclerosis. - 1988. - Vol. 8. - P. 227-236.
13. Wood D., Backer G. et al. // Eur. Heart J. - 1988. - Vol. 19. - P. 1434-1503.
14. World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension // J. Hypertens. - 1999. - Vol. 17. - P. 151 - 183.
15. Zavaroni J., Bonora E. et al. // N. Engl. J. Med. - 1989. - Vol. 320. - P. 702-706
Review
For citations:
Plokhaya A.A., Vorontsov A.V., Novolodskaya Yu.V., Butrova S.A., Dedov I.I. Anthropometric and hormonal-andmetabolic parameters in abdominal obesity. Problems of Endocrinology. 2003;49(4):18-22. (In Russ.) https://doi.org/10.14341/probl11672

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).